From Principles to Practice: Preparing for the Advent of Gene Therapy is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 1/11/2021
Valid for credit through: 1/11/2022

Accreditation:
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

For Nurses
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Goal Statement:
The goal of this activity is to prepare providers for real-world considerations with regard to successfully incorporating gene therapy into clinical practice.

Upon completion of this activity, participants will:
• Have increased knowledge regarding the
○ Practical considerations for incorporating gene therapy into care, should it become available
• Have greater competence related to
○ Identifying patients who may be candidates for gene therapy, should it become available
• Demonstrate greater confidence in their ability to
○ Engage with the interprofessional care team to best administer gene therapy, as appropriate